Skip to main content

and
  1. Article

    Open Access

    Therapy-related MDS dissected based on primary disease and treatment—a nationwide perspective

    In this population-based study, we aimed to characterize and compare subgroups of therapy-related Myelodysplastic syndromes (t-MDS) and define the implications of type of previous treatment and primary disease...

    Daniel Moreno Berggren, Hege Garelius, Petter Willner Hjelm, Lars Nilsson in Leukemia (2023)

  2. Article

    Open Access

    “Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)”

    Bengt Rasmussen, Gudrun Göhring, Elsa Bernard, Lars Nilsson, Magnus Tobiasson in Leukemia (2022)